Mitesh Kothari, MD
Obstetrics & Gynecology · Hagerstown, MDNPI 1306849799
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 26.4% of the total. Reporting peaked in 2021 at $398 and has fallen 79.9% since, to $80 in 2024.
Across 64 payments — averaging $20.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$353
- Bayer$178
- Astellas Pharma US Inc$138
- Aspira Women's Health Inc$95
- Mayne Pharma Commercial LLC$83
- Daiichi Sankyo Inc.$72
- plus $418 from 13 others
What the payments were for
- Food & beverage$1,30898%
- Education$302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $353 |
| Bayer | 11 | $178 |
| Astellas Pharma US Inc | 7 | $138 |
| Aspira Women's Health Inc | 1 | $95 |
| Mayne Pharma Commercial LLC | 5 | $83 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Therapeuticsmd, Inc. | 5 | $71 |
| Hologic Sales And Service, LLC | 3 | $60 |
| Duchesnay USA Incorporated | 2 | $44 |
| Organon | 3 | $44 |
| Axonics, Inc. | 2 | $43 |
| Innovation Technologies Inc | 1 | $37 |
| AMAG Pharmaceuticals, Inc. | 2 | $30 |
| Olympus America Inc. | 2 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Myovant Sciences Inc. | 1 | $13 |
| Agile Therapeutics, Inc. | 1 | $12 |
| Avion Pharmaceuticals | 1 | $11 |
How this compares
$1,337 in reported general payments places this provider in the 65th percentile of 842 obstetrics & gynecology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 14 | $490 |
| Alendronate Sodium | 14 | $87 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Hagerstown
- Otis StittSilver Spring$641K
- Danielle ShillerBaltimore$221K
- Matthew ReevesChevy Chase$149K
- Karen WangBaltimore$91K
- Rebecca StoneBaltimore$88K
- Abigail GregoryOakland$63K
- Christina EnzmannBaltimore$63K
- Lisa RarickChesapeake Beach$54K
- Logan PetersonBethesda$52K
- Latasha MurphyBaltimore$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.